SCHEMBL2648438

SCHEMBL2648438

CCCC=Cc1c(C(C)C)nc(C(C)C)c(CO)c1-c1ccc(F)cc1OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCGR P47871 18/20 0.44
CDK2 P24941 2/20 0.37
CDK9 P50750 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647364 0.91 GCGR (0.42) GCGR
SCHEMBL2648040 0.91 GCGR (0.42) GCGR
SCHEMBL2648946 0.89 GCGR (0.44) GCGRCDK2CDK9
SCHEMBL2648392 0.87 L3MBTL1 (0.40) CDK2CDK9
SCHEMBL2648389 0.87 L3MBTL1 (0.40) CDK2CDK9
SCHEMBL2647179 0.82 GCGR (0.64) GCGR
SCHEMBL2647177 0.82 GCGR (0.64) GCGR
SCHEMBL2654624 0.82 GCGR (0.49) GCGR
SCHEMBL2647812 0.80 GCGR (0.45) GCGR
SCHEMBL2647814 0.80 GCGR (0.45) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
EP-0934274-A1 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS Bayer Corporation (US) 1999-08-11 EP disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed